Valuation: Inotiv, Inc.

Market Cap 4L 3L 3L 3L 5L 3.73Cr 6L 37.33L 14.68L 1.83Cr 14.54L 14.22L 6.29Cr P/E 2024
-0.41x
P/E 2025 -0.69x
Enterprise Value 44Cr 38Cr 35Cr 33Cr 61Cr 4.22TCr 63Cr 422.11Cr 166.03Cr 2.07TCr 164.47Cr 160.86Cr 7.11TCr EV / Sales 2024
0.95x
EV / Sales 2025 0.95x
Free-Float
91.39%
Yield 2024 *
-
Yield 2025 -
1 day-26.00%
1 week-38.33%
Current month+7.77%
1 month-36.57%
3 months-95.99%
6 months-98.05%
Current year-98.03%
1 week 0.01
Extreme 0.011
0.03
1 month 0.01
Extreme 0.007
0.03
Current year 0.01
Extreme 0.007
0.65
1 year 0.01
Extreme 0.007
2.44
3 years 0.01
Extreme 0.007
11.42
5 years 0.01
Extreme 0.007
60.66
10 years 0.01
Extreme 0.007
60.66
Manager TitleAgeSince
Chief Executive Officer 67 12/01/2019
Director of Finance/CFO 61 06/03/2020
Compliance Officer 49 23/10/2023
Director TitleAgeSince
Chairman 71 26/03/2024
Director/Board Member 60 02/07/2018
Director/Board Member 67 12/01/2019
Date Insider Type Main position Quantity % Market Cap.
18/06/26 Tax

Chief Operating Officer

-5,769 0.0165%
18/06/26 Tax

Executive/Senior Manager

-5,371 0.0154%
18/06/26 Tax

Compliance Officer

-5,800 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
-26.00%-38.33%-99.37%-99.78% 4L
+3.90%-0.39%+376.72%+599.59% 3.96TCr
-1.70%+4.46%+7.46%+57.67% 3.47TCr
-2.01%-0.76%+26.35%-6.83% 3.44TCr
+0.06%+0.34%+2.32%+29.30% 2.71TCr
+0.46%-3.49% - - 1.62TCr
-0.04%-0.09%+68.48%+117.39% 1.54TCr
+1.12%+1.91%+15.90%+19.65% 1.41TCr
0.00%+1.36%+15.74%-30.62% 1.3TCr
-0.08%-3.01%+1,271.69%+649.69% 1.18TCr
Average -2.43%-3.80%+187.25%+148.45% 2.06TCr
Weighted average by Cap. +0.24%+0.36%+171.43%+187.42%

Financials

2024 2025
Net sales 49Cr 43Cr 40Cr 36Cr 69Cr 4.73TCr 70Cr 473.01Cr 186.04Cr 2.31TCr 184.3Cr 180.25Cr 7.97TCr 51Cr 45Cr 41Cr 38Cr 72Cr 4.94TCr 73Cr 494.49Cr 194.49Cr 2.42TCr 192.67Cr 188.44Cr 8.33TCr
Net income -11Cr -9.48Cr -8.75Cr -8.06Cr -15Cr -1.04TCr -16Cr -104.53Cr -41Cr -511.48Cr -41Cr -40Cr -1.76TCr -6.86Cr -6Cr -5.53Cr -5.1Cr -9.61Cr -660.87Cr -9.83Cr -66Cr -26Cr -323.67Cr -26Cr -25Cr -1.11TCr
Net Debt 42Cr 37Cr 34Cr 31Cr 59Cr 4.08TCr 61Cr 408.38Cr 160.63Cr 2TCr 159.12Cr 155.63Cr 6.88TCr 44Cr 38Cr 35Cr 33Cr 61Cr 4.21TCr 63Cr 421.74Cr 165.88Cr 2.06TCr 164.32Cr 160.72Cr 7.1TCr
Logo Inotiv, Inc.
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Employees
1,996
Date Price Change Volume
17/26/17 $0.0111 -26.00% 2,43,786
16/26/16 $0.0150 +32.74% 70,600
15/26/15 $0.0113 -13.08% 6,30,714
14/26/14 $0.0130 -26.97% 3,25,742
13/26/13 $0.0178 -1.11% 5,02,086
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOTVQ Stock